000 | 01167 a2200313 4500 | ||
---|---|---|---|
005 | 20250517234703.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1432-0843 | ||
024 | 7 |
_a10.1007/s00280-018-3674-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBanerji, Udai | |
245 | 0 | 0 |
_aCorrection to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models. _h[electronic resource] |
260 |
_bCancer chemotherapy and pharmacology _cNov 2018 |
||
300 |
_a911-912 p. _bdigital |
||
500 | _aPublication Type: Published Erratum | ||
700 | 1 | _aSain, Nivedita | |
700 | 1 | _aSharp, Swee Y | |
700 | 1 | _aValenti, Melanie | |
700 | 1 | _aAsad, Yasmin | |
700 | 1 | _aRuddle, Ruth | |
700 | 1 | _aRaynaud, Florence | |
700 | 1 | _aWalton, Michael | |
700 | 1 | _aEccles, Suzanne A | |
700 | 1 | _aJudson, Ian | |
700 | 1 | _aJackman, Ann L | |
700 | 1 | _aWorkman, Paul | |
773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 82 _gno. 5 _gp. 911-912 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-018-3674-9 _zAvailable from publisher's website |
999 |
_c28794321 _d28794321 |